Q3 2025 Earnings Call Transcript November 3, 2025 Karyopharm Therapeutics Inc. misses on earnings expectations. Reported EPS ...
NewcelX Ltd. (Nasdaq: NCEL), a Swiss clinical-stage biopharmaceutical company developing cell-based and small-molecule therapies ...
Q3 2025 Earnings Call November 4, 2025 8:00 AM ESTCompany ParticipantsNathan Rozof - Head of Investor RelationsCameron Bready ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback